Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments
Disease area: Airway diseases, Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
N. Kuzubova, E. Lebedeva, A. Fedin, T. Preobrazhenskaya (St. Petersburg, Russian Federation). Dilatation reserve of pulmonary arteries at stages of COPD experimental model. Eur Respir J 2013; 42: Suppl. 57, 487

Member's Comments

No comment yet.

Related content which might interest you: Effect of drugs with pleiotropic properties on tone of pulmonary arteries and bronchi in obstructive lung pathology model Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease Year: 2015 Animal models of pulmonary emphysema: a stereologist's perspective Source: Eur Respir Rev 2006; 15: 136-147 Year: 2006 Formation of typical vascular lesions in a new experimental model of pulmonary arterial hypertension Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments Year: 2013 Role of survivin in experimental models of pulmonary arterial hypertension Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside Year: 2016 A novel non-human primate model of cigarette smoke-induced chronic obstructive pulmonary disease Source: International Congress 2014 – Animal models: asthma, COPD and beyond Year: 2014 Effect of diminazene on monocrotalin-induced pulmonary hypertension rat model Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease Year: 2015 Renal denervation reduces pulmonary vascular remodeling in two experimental pulmonary arterial hypertension models Source: International Congress 2015 – Pulmonary hypertension: new treatment insights Year: 2015 LATE-BREAKING ABSTRACT: Pneumonectomy combined with SU5416: a novel animal model of pulmonary hypertension Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments Year: 2013 Elastase-induced emphysema is attenuated by L-carnitine supplementation Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema Year: 2015 Lung function measurements in mouse models of lung disease: What to expect from FEV0.1? Source: International Congress 2016 – Functional assessment of the airways Year: 2016 Effects of intermittent hypoxia on pulmonary haemodynamics: animal models versus studies in humans Source: Eur Respir J 2005; 25: 173-180 Year: 2005 LATE-BREAKING ABSTRACT: Research of large aperture fenestration emphysema model in pigs Source: International Congress 2016 – Clinical characteristics of asthma Year: 2016 Erythropoietin recapitulates hemodynamic features of hypoxia-induced pulmonary hypertension in mice Source: International Congress 2016 – The nature of pulmonary hypertension Year: 2016 Characterization of a new rat model of heritable PAH Source: International Congress 2016 – Pulmonary hypertension: novel insights Year: 2016 Animal models of pulmonary hypertension in COPD Source: Annual Congress 2010 - Pulmonary vascular involvement in COPD Year: 2010 Mepenzolate bromide displays beneficial effects in a mouse model of chronic obstructive pulmonary disease Source: International Congress 2014 – Animal models in respiratory drug development Year: 2014 Developing a chronic murine model that better reflects the clinical features of the human asthma Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma Year: 2016 Non-invasive monitoring of emphysema and muscle wasting during experimental disease exacerbation Source: International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease Year: 2016 Role of the TrkA receptor in experimental severe pulmonary hypertension Source: International Congress 2015 – Pulmonary hypertension: promising small molecules Year: 2015